Evolution of the health economics of cervical cancer vaccination

N Ferko, M Postma, S Gallivan, D Kruzikas… - Vaccine, 2008 - Elsevier
N Ferko, M Postma, S Gallivan, D Kruzikas, M Drummond
Vaccine, 2008Elsevier
This paper reviews the history of modelling for cervical cancer vaccination. We provide an
interpretation and summary of conclusions pertaining to the usefulness of different models,
the predicted epidemiological impact of vaccination and the cost-effectiveness of
adolescent, catch-up and sex-specific vaccination strategies. To date, model results predict
a critical role for vaccination in reducing the burden of cervical disease, with cost-
effectiveness being consistently shown across studies using a common threshold of US …
This paper reviews the history of modelling for cervical cancer vaccination. We provide an interpretation and summary of conclusions pertaining to the usefulness of different models, the predicted epidemiological impact of vaccination and the cost-effectiveness of adolescent, catch-up and sex-specific vaccination strategies. To date, model results predict a critical role for vaccination in reducing the burden of cervical disease, with cost-effectiveness being consistently shown across studies using a common threshold of US $50,000 per QALY, but further clinical and epidemiological data are required to confirm these findings. Through this paper, we aim to provide useful insights for decision-makers as they examine how to best evaluate the potential impact of vaccines against cervical cancer and determine how to best incorporate vaccination into practice.
Elsevier
以上显示的是最相近的搜索结果。 查看全部搜索结果